NCT06168292Recruiting
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma: A Prospective, Single-arm, Multicenter Study
Source: ClinicalTrials.gov · Last updated 19 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
\[Study objectives\] To evaluate the efficacy and safety of the combined treatment of radiotherapy and endoscopic intraductal radiofrequency ablation in patients with locoregional extrahepatic cholangiocarcinoma.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 53 (estimated)
- First submitted
- 26 Nov 2023
- Start date
- 1 Apr 2024
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- National Cancer Center, Korea
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06168292
What you commit to
- Study type: Interventional
- Planned participants: 53
- From 1 Apr 2024 to the primary completion date, 30 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with metastatic cancer (stage IV) or malignant ascites
Lab values
- Patients with ID-RFA contraindications: pacemaker, pregnancy, uncorrected bleeding tendency (PT INR \> 1.5, platelets \< 50,000/mm3)
Other
- Patients who refuse to sign the informed consent
- Patients with intrahepatic cholangiocarcinoma
- Patients who are unable to undergo endoscopic procedures as determined by the investigator.
- Patients with a life expectancy of 3 months or less
Who the study is looking for
- Patients 20 years of age or older, who voluntarily agree to participate in the study and sign the informed consent.
- Patients with cytopathologically diagnosed inoperable extrahepatic cholangiocarcinoma
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Cancer Center - Korea Coordinator of this site? Confirm its status | Goyang-si | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.